312 related articles for article (PubMed ID: 11896607)
1. Silibinin inhibits constitutive and TNFalpha-induced activation of NF-kappaB and sensitizes human prostate carcinoma DU145 cells to TNFalpha-induced apoptosis.
Dhanalakshmi S; Singh RP; Agarwal C; Agarwal R
Oncogene; 2002 Mar; 21(11):1759-67. PubMed ID: 11896607
[TBL] [Abstract][Full Text] [Related]
2. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
Shukla S; Gupta S
Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
[TBL] [Abstract][Full Text] [Related]
3. Inositol hexaphosphate inhibits constitutive activation of NF- kappa B in androgen-independent human prostate carcinoma DU145 cells.
Agarwal C; Dhanalakshmi S; Singh RP; Agarwal R
Anticancer Res; 2003; 23(5A):3855-61. PubMed ID: 14666688
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of NF-kappaB pathway in grape seed extract-induced apoptotic death of human prostate carcinoma DU145 cells.
Dhanalakshmi S; Agarwal R; Agarwal C
Int J Oncol; 2003 Sep; 23(3):721-7. PubMed ID: 12888909
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha-induced apoptosis in prostate cancer cells through inhibition of nuclear factor-kappaB by an IkappaBalpha "super-repressor".
Muenchen HJ; Lin DL; Walsh MA; Keller ET; Pienta KJ
Clin Cancer Res; 2000 May; 6(5):1969-77. PubMed ID: 10815922
[TBL] [Abstract][Full Text] [Related]
6. Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells.
Jin F; Liu X; Zhou Z; Yue P; Lotan R; Khuri FR; Chung LW; Sun SY
Cancer Res; 2005 Jul; 65(14):6354-63. PubMed ID: 16024638
[TBL] [Abstract][Full Text] [Related]
7. Effect of silibinin in human colorectal cancer cells: targeting the activation of NF-κB signaling.
Raina K; Agarwal C; Agarwal R
Mol Carcinog; 2013 Mar; 52(3):195-206. PubMed ID: 22086675
[TBL] [Abstract][Full Text] [Related]
8. Aspirin inhibits TNFalpha- and IL-1-induced NF-kappaB activation and sensitizes HeLa cells to apoptosis.
Kutuk O; Basaga H
Cytokine; 2004 Mar; 25(5):229-37. PubMed ID: 15036249
[TBL] [Abstract][Full Text] [Related]
9. Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells.
Agarwal C; Tyagi A; Kaur M; Agarwal R
Carcinogenesis; 2007 Jul; 28(7):1463-70. PubMed ID: 17341659
[TBL] [Abstract][Full Text] [Related]
10. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis.
Manna SK; Mukhopadhyay A; Van NT; Aggarwal BB
J Immunol; 1999 Dec; 163(12):6800-9. PubMed ID: 10586080
[TBL] [Abstract][Full Text] [Related]
11. Jesterone dimer, a synthetic derivative of the fungal metabolite jesterone, blocks activation of transcription factor nuclear factor kappaB by inhibiting the inhibitor of kappaB kinase.
Liang MC; Bardhan S; Li C; Pace EA; Porco JA; Gilmore TD
Mol Pharmacol; 2003 Jul; 64(1):123-31. PubMed ID: 12815168
[TBL] [Abstract][Full Text] [Related]
12. The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells.
Gasparian AV; Yao YJ; Kowalczyk D; Lyakh LA; Karseladze A; Slaga TJ; Budunova IV
J Cell Sci; 2002 Jan; 115(Pt 1):141-51. PubMed ID: 11801732
[TBL] [Abstract][Full Text] [Related]
13. Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells.
Ling MT; Wang X; Ouyang XS; Xu K; Tsao SW; Wong YC
Oncogene; 2003 Jul; 22(29):4498-508. PubMed ID: 12881706
[TBL] [Abstract][Full Text] [Related]
14. Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway.
Deeb D; Jiang H; Gao X; Al-Holou S; Danyluk AL; Dulchavsky SA; Gautam SC
J Pharmacol Exp Ther; 2007 May; 321(2):616-25. PubMed ID: 17289836
[TBL] [Abstract][Full Text] [Related]
15. A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells.
Zi X; Grasso AW; Kung HJ; Agarwal R
Cancer Res; 1998 May; 58(9):1920-9. PubMed ID: 9581834
[TBL] [Abstract][Full Text] [Related]
16. Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation.
Roussel RR; Barchowsky A
Arch Biochem Biophys; 2000 May; 377(1):204-12. PubMed ID: 10775461
[TBL] [Abstract][Full Text] [Related]
17. NF-kappaB activation during Rickettsia rickettsii infection of endothelial cells involves the activation of catalytic IkappaB kinases IKKalpha and IKKbeta and phosphorylation-proteolysis of the inhibitor protein IkappaBalpha.
Clifton DR; Rydkina E; Freeman RS; Sahni SK
Infect Immun; 2005 Jan; 73(1):155-65. PubMed ID: 15618150
[TBL] [Abstract][Full Text] [Related]
18. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1.
Shishodia S; Majumdar S; Banerjee S; Aggarwal BB
Cancer Res; 2003 Aug; 63(15):4375-83. PubMed ID: 12907607
[TBL] [Abstract][Full Text] [Related]
19. Silibinin sensitizes human prostate carcinoma DU145 cells to cisplatin- and carboplatin-induced growth inhibition and apoptotic death.
Dhanalakshmi S; Agarwal P; Glode LM; Agarwal R
Int J Cancer; 2003 Sep; 106(5):699-705. PubMed ID: 12866029
[TBL] [Abstract][Full Text] [Related]
20. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
